This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Key scenarios for using a hot wallet, plus risk considerations and tips to keep funds safe during everyday transactions.
17,534 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Evernorth has filed Form S-4 as it advances a merger with Armada Acquisition Corp. II to take a Nasdaq-listed XRP tre...
A private AI-focused XR company invites retail investors to participate in a sub-$1 pre-IPO round, offering bonus sha...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
Private firms are now on the front lines of geopolitics as digital and physical infrastructure becomes a battlefield....
Gas prices climb as policy gains from the One Big Beautiful Bill Act spark optimism. Economists warn the higher fuel ...
U.S. prosecutors allege a scheme to move Nvidia GPUs and servers to China, with Supermicro’s co-founders at the cente...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
As the world leans harder on reliable, low-emission power, these nuclear energy stocks could offer compelling opportu...
As drone-saturated battlefields rise, the world’s most advanced tanks drive a new era of defense spending. This repor...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...